Harvard Bioscience Inc

HBIO NASDAQ Healthcare & Biotech Monde US4169061052
5.59 $
1.27 %

Harvard Bioscience Inc. is a provider of solutions and devices for scientific research in the fields of biology, pharmacology, and medicine.

Price history of Harvard Bioscience Inc
Price history of Harvard Bioscience Inc

Performance & Momentum

6 Months 13.75 %
1 Year 67.27 %
3 Years 90.60 %
5 Years 92.28 %

Strategic Analysis

Harvard Bioscience Inc • 2026

Harvard Bioscience Inc positions itself as a specialized provider of scientific research equipment for biology and biotechnology, primarily serving academic and industrial laboratories. Its niche is based on offering instruments dedicated to pharmacology and medicine, with a focus on the precision and quality of the proposed solutions.

Strengths
  • Positioning within a niche sector with highly substitutable technical products
  • Stable presence in the U.S. market, one of the global leaders in biomedical research
  • Recognized expertise in developing devices tailored to the specific needs of laboratories
Weaknesses
  • Significant negative stock performance over the medium and long term, indicating structural difficulties
  • Neutral momentum that does not favor a short-term investment dynamic
Momentum

The current momentum is neutral, coupled with low positive visibility in the short term. This profile suggests a phase of consolidation or search for growth drivers, without notable immediate catalysts, which requires caution for investors looking for a quick recovery.

Similar stocks to Harvard Bioscience Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone